Lelia Nichols
Nurse Practitioner · Dallas, TXNPI 1164658142
Payments from drug & device makers
Across 648 payments — averaging $20.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Sun Pharmaceutical Industries Inc.$1K
- Johnson & Johnson$997
- Novartis$876
- Sanofi$753
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$734
- plus $6K from 30 others
What the payments were for
- Food & beverage$13,07597%
- Education$3623%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 143 | $2,644 |
| Sun Pharmaceutical Industries Inc. | 50 | $1,496 |
| Johnson & Johnson | 49 | $997 |
| Novartis | 45 | $876 |
| Sanofi | 30 | $753 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 38 | $734 |
| Lilly USA, LLC | 29 | $681 |
| Abbott | 29 | $643 |
| Regeneron Healthcare Solutions, Inc. | 24 | $621 |
| LEO Pharma Inc. | 23 | $581 |
| Amgen | 21 | $532 |
| Arcutis Biotherapeutics, Inc. | 45 | $499 |
| E.r. Squibb & Sons, L.L.C. | 21 | $470 |
| UCB, Inc. | 14 | $285 |
| Galderma Laboratories, L.p. | 13 | $239 |
| Mayne Pharma Commercial LLC | 14 | $209 |
| Incyte Corporation | 11 | $208 |
| Boehringer Ingelheim | 7 | $170 |
| Pfizer | 8 | $151 |
| Helsinn Therapeutics (U.S.), Inc. | 7 | $117 |
| Revance Therapeutics, Inc. | 1 | $79 |
| Dermavant Sciences, Inc. | 4 | $60 |
| Biofrontera Inc. | 3 | $57 |
| Journey Medical Corporation | 3 | $47 |
| Nevro Corp. | 2 | $36 |
| Botanix SB Inc | 2 | $34 |
| Organon | 3 | $31 |
| Genentech USA, Inc. | 1 | $29 |
| Scilex Pharmaceuticals Inc. | 1 | $25 |
| EPI Health, LLC | 1 | $24 |
| Fresenius Kabi USA, LLC | 1 | $22 |
| Hikma Pharmaceuticals USA | 1 | $21 |
| Mission Pharmacal Company | 1 | $21 |
| Almirall LLC | 1 | $18 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| Almatica Pharma LLC | 1 | $13 |
How this compares
$13,437 in reported general payments places this provider in the 95th percentile of 5,422 nurse practitioner providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Betamethasone Dipropionate | 26 | $1,057 |
| Ketoconazole | 64 | $930 |
| Doxycycline Hyclate | 51 | $869 |
| Triamcinolone Acetonide | 39 | $733 |
| Clobetasol Propionate | 19 | $619 |
| Mupirocin | 73 | $507 |
| Fluticasone Propionate | 24 | $479 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 13 | $45 |
| Prednisone | 14 | $40 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Dallas
- Samantha OnealDallas$133K
- Tam TranDallas$37K
- Tobin SpeightDallas$35K
- Rachel TiuDallas$19K
- Cecilia DavisAustin$262K
- Melanie MorrisHouston$254K
- Stephanie BrownHarlingen$235K
- Brittney MisercolaKilleen$223K
- Roger ChapmanTyler$211K
- Kelly BrassilHouston$194K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.